Contagion Live

Contagion® serves as a comprehensive news platform dedicated to all aspects of infectious diseases. Our offerings include a website, a quarterly journal, email newsletters, social media updates, and the Outbreak Monitor. These resources deliver targeted information to healthcare professionals and specialists, aimed at enhancing patient care and aiding in the identification, diagnosis, treatment, and prevention of infectious diseases. Our goal is to empower both the healthcare community and the public with valuable knowledge, enabling better decision-making that positively influences patient outcomes.

International

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#421207

United States

#179599

Health/Health Conditions and Concerns

#453

Traffic sources

Monthly visitors

Articles

When Will the Measles Outbreak End?

2 days ago | contagionlive.com | John Parkinson |Paul A. Offit

The Johns Hopkins Bloomberg School of Public Health’s Center for Outbreak Response Innovation has a measles outbreak tracker.
Hepatitis D Patients Maintain Undetectable Virus Nearly 2 Years After Bulevirtide Therapy

5 days ago | contagionlive.com | John Parkinson |Anu Osinusi

In a late-breaking oral presentation at EASL, 36% (23 out of 64) of adults living with chronic hepatitis delta virus (HDV) who were treated with the first-in-class entry inhibitor bulevirtide, at either a 2 mg or 10 mg dose, maintained virologic suppression for nearly 2 years after treatment, following undetectable HDV RNA when they finished their treatment. These findings were part of Gilead’s phase 3 MYR301 trial.
Gilead’s Bulevirtide Demonstrates Long-Term Sustained Virologic Response For Hepatitis D

6 days ago | contagionlive.com | John Parkinson |Anu Osinusi

At the ongoing European Association for the Study of the Liver (EASL) Congress 2025, Gilead announced findings on its hepatitis D (HDV) therapy, bulevirtide. Specifically, the therapy was studied as a standalone treatment and in combination with pegylated interferon alpha (PegIFN).
Hepatitis A Outbreak Declared in Los Angeles County

1 week ago | contagionlive.com | Sophia Abene

The Los Angeles County Department of Public Health has declared a community-wide hepatitis A outbreak following a sharp rise in cases and increased virus levels detected in wastewater. Since 2024, 165 cases have been confirmed, three times the total reported in 2023. Most of the 29 cases identified in 2025 have occurred in individuals without known risk factors such as homelessness or travel, signaling broader community transmission.
HCV Therapy Demonstrates 98% Sustained Virologic Response at 12 Weeks Post-Treatment

1 week ago | contagionlive.com | John Parkinson

At the ongoing European Association for the Study of the Liver (EASL) Congress 2025, Atea Pharmaceuticals announced the full results from its phase 2 clinical trial, which showed a 98% sustained virologic response rate at 12 weeks post-treatment (SVR12) in 210 of 215 participants with the regimen in the “Per-Protocol Treatment-Adherent Population,” using an 8-week treatment duration.
Over 1 Million Drug-Resistant Infections Went Untreated Across LMICs

1 week ago | contagionlive.com | Sophia Abene

A new modeling study has found that only 6.9% of carbapenem-resistant Gram-negative (CRGN) bacterial infections received appropriate treatment in 2019 across eight low- and middle-income countries (LMICs). The analysis, led by Anant Mishra and colleagues, estimates that while approximately 1.5 million CRGN infections occurred in Bangladesh, Brazil, Egypt, India, Kenya, Mexico, Pakistan, and South Africa, only about 103,000 courses of effective antibiotics were procured.
Has Measles Become a Binary Choice Between Trying to Treat the Disease Vs Prevention?

1 week ago | contagionlive.com | John Parkinson |Paul A. Offit

Health and Human Services Secretary Robert F Kennedy Jr is reported to have asked the Centers for Disease Control and Prevention (CDC) to develop new guidance for treating measles with therapies and vitamins.
"Not Touched by the Hand of a Person" as Vibrant's Automated Microarray Advances Lyme Disease Testing

1 week ago | contagionlive.com | Sophia Abene

In the third part of our interview series with Jason Barker, ND, clinical lab educator at Vibrant Wellness, the conversation focused on a recent Nature study that outlines a novel methodology for detecting Borrelia infections. This approach uses a highly sensitive and fully automated protein microarray system developed by Vibrant, offering greater diagnostic accuracy, faster turnaround times, and cost efficiency compared to standard two-tier Lyme disease testing.
Study Highlights Airborne Transmission of H5N1 in Ferrets, Raising Pandemic Concerns

1 week ago | contagionlive.com | Sophia Abene

A recent study of the highly pathogenic avian influenza A(H5N1) virus isolated from a dairy farm worker in Michigan has revealed concerning findings about its transmission capabilities. The virus, A/Michigan/90/2024 (MI90), was shown to transmit via airborne particles in a controlled ferret model and cause moderate disease, suggesting a possible shift in the virus’s capacity to infect humans and spread in mammalian populations.
Dual Salmonella Threats Spark Federal Health Alerts

1 week ago | contagionlive.com | Sophia Abene

Federal and state health officials are investigating a Salmonella Mbandaka outbreak linked to contact with backyard poultry that has sickened seven individuals across six states. As of April 24, 2025, cases have been reported in Utah (1), South Dakota (1), Wisconsin (1), Illinois (1), Missouri (2), and Florida (1). Illnesses occurred between February 9 and March 24.